Chronic hepatitis: An update with guidelines for histopathological assessment of liver biopsies

Pathology

Volumn 30, Issue 4, 1998, Pages 369-380

  Hall, Pauline De La M ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Autoimmune hepatitis; Chronic hepatitis; Hepatitis B virus; Hepatitis C virus; Liver damage

Indexed keywords

AUTOIMMUNE DISEASE; CHRONIC HEPATITIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG MONITORING; DYSPLASIA; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; REVIEW; BIOPSY; LIVER; LIVER TUMOR; PATHOLOGY; PRACTICE GUIDELINE; PRECANCER; STANDARD;

BIOPSY; CARCINOMA, HEPATOCELLULAR; HEPATITIS, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 0031769667     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169656     Document Type: Article

References (68)

1. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
2. Leevy CM, Popper H, Sherlock S. Diseases of the liver and biliary tract. Standardisation of nomenclature, diagnostic criteria and diagnostic methodology. Washington, DC: Government Printing Office, 1976; DHEW publication no. (NIH) 76-725. ( Fogarty International Center Proceeding, no. 22).
3. Leevy CM, Popper H, Sherlock S. Diseases of the liver and biliary tract. Standardisation of nomenclature, diagnostic criteria and diagnostic methodology. Washington, DC: Government Printing Office, 1976; DHEW publication no. (NIH) 76-725. ( Fogarty International Center Proceeding, no. 22).
4. Johnson PJ, McFarlane IG. Convenors, on behalf of the panel. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 988-1005.
5. Bénichou C. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990; 11: 272-26.
6. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993; 105: 1824-32.
7. Powell LW. The nature of cell death in piecemeal necrosis: is order emerging from chaos? Hepatology 1987; 7: 794-6.
8. Ishak K, Baptista A, Bianchi L, Callea F, de Groote J, Gudat F. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
9. Bianchi L, Gudat F. Pathology of the Liver. 3rd ed. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC. editors. Pathology of the liver. 3rd ed. Edinburgh: Churchill Livingstone, 1994; Chapter 9.
10. Gerber MA. The diagnostic value of immunohistochemical demonstration of hepatitis viral antigens in the liver. Hum Pathol 1987; 18: 771-4.
11. Thung SN, Gerber MA. Immunohistochemical study of delta antigen in an American metropolitan population. Liver 1983; 3: 392-7.
12. Allaire GS, Goodman ZD, Ishak KG, Rabin L. Talc in liver tissue of intravenous drug abusers with chronic hepatitis. A comparative study. Am J Clin Pathol 1989; 92: 583-8.
13. Scheuer PJ, Ashafratzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567-71.
14. Bach N, Thung SN, Schaffner F. The histology of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15: 572-7.
15. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HCJ, et al. Pathological diagnosis of chronic hepatitis C: a mulitcentre comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993; 104: 595-603.
16. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995; 15: 70-81.
17. Gerber MA, Krawczynski K, Alter MJ, Sampliner RE, Margolis HS. Histopathology of community acquired chronic hepatitis C. Mod Pathol 1992; 5: 483-6.
18. Goldin RD, Patel NK, Thomas HC. Hepatitis C and bile duct loss. J Clin Pathol 1996; 49: 836-8.
19. Haque S, Chandra B, Gerber MA, Lok ASF. Iron overload in patients with chronic hepatitis C: A clinicopathological study. Hum Pathol 1996; 27: 1277-81.
20. Olynyk JK, Reddy KR, Di Bisceglie AM, Jefers LJ, Parker TI, Radick JL, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995; 108: 1104-9.
21. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, Mori C, et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 1992; 16: 306-11.
22. Chamlian A, Benkoel L, Sahel J, Cherid A, Brisse J, Ikoli JF, et al. Immunohistochemical detection of hepatitis C virus related C 100-3 and core antigens in formalin-fixed tissue. Cell Mol Biol Noisy le Grand 1996; 42: 557-66.
23. Emile JF, Sebagh M, Feray C, David F, Reynes M. The presence of epithelioid granulomas in hepatitis C virus related cirrhosis. Hum Pathol 1993; 24: 1095-7.
24. Goldin RD, Levine TS, Foster GR, Thomas HC. Granulomas and hepatitis C. Histopathology 1995; 28: 265-7.
25. Zimmerman HJ, Ishak KG. Drug-induced and toxic liver injury. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portman BC, editors. Pathology of the liver. 3rd ed. Edinburgh: Churchill Livingstone, 1994; Chapter 6.
26. Hall P. de la M. Pathological spectrum of drug-induced liver disease. In: Farrell GC, editor. Drug-induced liver disease. Edinburgh: Churchill Livingstone, 1994; Chapter 6.
27. Vento S, Garofano T, Di Perri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individual. Lancet 1991; 337: 1183-7.
28. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10-5.
29. Tsui WMS, Lam TW. The mystery of autoimmune cholangitis: a new entity or a variant? Adv Anat Pathol 1997; 4: 64-9.
30. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet 1968; ii: 628-8.
31. Popper H, Schaffner F. The vocabulary of chronic hepatitis. New Engl J Med 1971; 284: 1154-6.
32. Scheuer PJ. Classification of chronic hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-4.
33. Gerber MA. Chronic hepatitis C: the beginning of the end of a time-honoured nomenclature? Hepatology 1992; 15: 733-4.
34. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274-8.
35. Hytiroglou P, Thung SN, Gerber MA. Histological classification and quantitation of the severity of chronic hepatitis: keep it simple! Semin Liver Dis 1995, 15: 414-21.
36. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-17.
37. Knodell RG, Ishak KG, Black WC, Chent S, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
38. Lok ASF, Lindsay I, Scheuer PJ, Thomas HC. Clinical and histological features of delta infection in chronic hepatitis B virus carriers. J Pathol 1985; 38: 530-3.
39. Camma C, Giunta M, Linea C, Pagliaro L. The effect of interferon on liver histology in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis. J Hepatol 1997; 26: 1187-99.
40. Scheuer PJ. Scoring of liver biopsies: are we doing it right? Eur J Gastroenterol Hepatol 1996; 8: 1141-3.
41. Scheuer PJ. Chronic hepatitis: what is activity and how should it be assessed? Histopathology 1997; 30: 103-5.
42. Cooksley WG, Bradbear RA, Robinson W, Harrison M, Halliday JW, Powell LW, et al. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 1986; 6: 354-8.
43. Chen T-J, Liaw Y-F. The prognostic significance of bridging necrosis in chronic type B hepatitis: a histopathological study. Liver 1988; 8: 10-6.
44. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
45. Goldin RD, Goldin JG, Burt AD, Dhillon PA, Hubscher S, Wyatt J, Patel N, et al., Intra-observer and inter-observer variation in the assessment of chronic viral hepatitis. J Hepatol 1996; 25: 649-54.
46. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group, Hepatology 1996; 24: 289-93.
47. Vaquer P, Canet R, Llompart A, Riera J, Obrador A, Gaya J. Histological evolution of chronic hepatitis C. Factors related to progression. Liver 1994; 14: 265-9.
48. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
49. Yoshioka K, Higashi Y, Yamada M, Aiyama T, Takayanagi M, Tanaka K, et al. Predictive factors in the response to interferon therapy in chronic hepatitis C. Liver 1995; 15: 57-62.
50. Nomura H, Kimura Y, Tada H, Hisano C, Morita C, Okamoto O, et al. Predictive factors of a response to interferon therapy in chronic hepatitis C. J Clin Gastroenterol 1996; 23: 185-90.
51. Alvarez F. Therapy for chronic viral hepatitis. Clin Invest Med 1996; 19: 381-8.
52. Di Biseeglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Int Med 1988; 108: 390-401.
53. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, et al. Detection of hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992; 16: 637-41.
54. Takeda S, Shibata M, Morishima T, Harada A, Nakao A, Takagi H, et al. Hepatitis C virus infection in hepatocellular carcinoma. Cancer 1992; 70: 2255-9.
55. Bukh J, Miller RH, Kew MC, Purcell RH. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci USA 1993; 90: 1848-51.
56. Brechot C, Nalplas B, Feitelson MA. Interactions between alcohol and hepatitis viruses in the liver. Clin Lab Med 1996; 16: 273-87.
57. Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88: 39-43.
58. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994; 19: 222-6.
59. Theise ND, Schwartz M, Miller C, Thung SN. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology 1992; 16: 949-55.
60. Ferrell L, Wright T, Lake J, Robert J, Ascher N. The incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology 1992; 16: 1372-81.
61. Okuda K, Nakashima T, Kojiro M, Kondo Y, Wada K. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterolgy 1989; 97: 140-6.
62. Herr W, Gerken G, Poralla T, Immenschuh S, Schirmacher P, Steegmuller KW, et al. Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver. Clin Invest 1993; 71: 49-53.
63. el-Refaie A, Savage K, Bhattacharya S, Khakoo S, Harrison JJ, el-Batanony M, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol 1996; 24: 277-85.
64. Lefkowitch JH, Apfelbaum TF. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis. Arch Pathol Lab Med 1987; 111: 170-3.
65. Ferrell LD, Crawford JM, Dihillon AP, Dhillon AP, Scheuer PJ, Nakanuma Y. Proposal for standardized criteria for the diagnosis of benign, borderline and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 1993; 17: 1113-23.
66. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
67. Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chagger K, Alexander GJ, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of sclerosing cholestatic hepatitis. Hepatology 1989; 13: 150-7.
68. Schlugler LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971-6.